Sale disclosed
Steven Leonard Chapman
CEO AND PRESIDENT
Common Stock
- Reported value
- $526.14K
- Reported price
- $413.31 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Natera, Inc.
Last 30 daysNo qualifying insider buying. Sales: $63.19M by 4 insiders.
Showing the first 6 of 20 trades on this page.
CEO AND PRESIDENT
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CEO AND PRESIDENT | Common StockSale10b5-1 | 1,273$413.31 / share | $526.14K | Oct 1Filed Oct 2 · 1d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-13 trades | 3,000avg $414.22 / share | $1.24M | Oct 1Filed Oct 2 · 1d later | 3 filings
|
| Director | Common StockSale10b5-112 trades | 18,064avg $388.01 / share | $7.01M | Sep 23Filed Sep 25 · 2d later | 12 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockGift | 945Gift · no purchase price | Not a purchase | Sep 16Filed Sep 18 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 6,000$350.07 / share | $2.1M | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 300avg $348.37 / share | $104.51K | Sep 16Filed Sep 17 · 1d later | 2 filings
|
Showing the latest 20 of 310 trades. Show all 310 trades
Natera, Inc. - Common Stock (NTRA) · Stock
The filing reports a purchase for a joint account.
Josh GottheimerReporting House member